Delivery Order SPE2DB24D2013-SPE2DB25FCKDB
- Not listed
- The Defense Logistics Agency (DLA) awarded a $2,351.58 delivery order to AmerisourceBergen Drug Corp for 90-count bottles of Nexium DR 40 mg capsules. This firm fixed-price contract, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a direct delivery order under AmerisourceBergen's broader pharmaceutical supply agreement. The contract utilizes no set-aside designation and was awarded competitively. Performance will occur at the contractor's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for NEXIUM DR 20 mg capsules (90-count) valued at $1,299.08 under a firm fixed-price contract type. The award, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-competitive delivery against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania—the...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency for NEXIUM DR 40 mg capsules (90-count units) valued at $1,125.04 with a firm fixed price structure. The award, issued on August 28, 2025, is set to be completed by August 29, 2025, and represents a non-set-aside, competitively awarded contract. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Nexium DR 40 mg capsules (30-count packages) with a ceiling value of $2,250.24. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,726.23 to AmerisourceBergen Drug Corp for 90-count bottles of Nexium DR 40 mg capsules on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside, firm fixed price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award was fulfilled by AmerisourceBergen's Corporate Office division, located in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,279.72 to AmerisourceBergen Drug Corp for 90-count bottles of Nexium DR 40 mg capsules, with an ultimate completion date of July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply...
- The Defense Logistics Agency awarded a $17,748.41 delivery order to AmerisourceBergen Drug Corp for 90-count supplies of Nexium DR 20 mg capsules on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The contract was awarded without set-aside provisions through open competition, reflecting the vendor's established capability to meet federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $8,400.65 to AmerisourceBergen Drug Corp for the supply of Nexium DR 40 mg capsules (90-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is performing the work at...
- This delivery order, awarded August 12, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 90-count supplies of Nexium DR 40 mg capsules with a ceiling value of $2.81K under firm fixed pricing. The award is non-competitive and represents a child contract under AmerisourceBergen's substantial $1 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,264.48 to AmerisourceBergen Drug Corp for 90 capsules of Nexium DR 40 mg on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price, non-set-aside contract represents a pharmaceutical supply delivery to support federal medical procurement needs. The contract is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCKDBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,369.77 to AmerisourceBergen Drug Corp for 90-count bottles of Nexium DR 40 mg capsules. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor contract running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to meet diverse medical supply requirements through open competition. This delivery order for Nexium, a gastroesophageal reflux disease medication, is representative of the company's role in supplying brand-name and generic pharmaceuticals across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 9/8/25 |